<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press Releases</title>
	<atom:link href="https://www.worldpharmatoday.com/press-releases/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Thu, 02 Apr 2026 12:29:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Press Releases</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>eschbach Unveils Shiftconnector Activity Scheduler</title>
		<link>https://www.worldpharmatoday.com/press-releases/eschbach-unveils-shiftconnector-activity-scheduler/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 02 Apr 2026 12:29:36 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/eschbach-unveils-shiftconnector-activity-scheduler/</guid>

					<description><![CDATA[<p>New feature helps pharma manufacturing teams streamline daily production planning, reduce manual work and improve on time batch execution. eschbach today announced the release of its new Shiftconnector Activity Scheduler, a feature designed to replace the spread sheet driven planning still common in pharmaceutical production environments with real time, equipment level scheduling and automated coordination. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/eschbach-unveils-shiftconnector-activity-scheduler/">eschbach Unveils Shiftconnector Activity Scheduler</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Kindeva® commemorates 70 years of pMDI Innovation</title>
		<link>https://www.worldpharmatoday.com/press-releases/kindeva-commemorates-70-years-of-pmdi-innovation/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 25 Mar 2026 13:33:05 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/kindeva-commemorates-70-years-of-pmdi-innovation/</guid>

					<description><![CDATA[<p>Kindeva® commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’ Kindeva, a global CDMO and drug delivery innovator, commemorates 70 years today, since the invention of the pressurized metered dose inhaler (pMDI), a breakthrough therapy that transformed respiratory care across the globe. Marking this momentous milestone, the [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/kindeva-commemorates-70-years-of-pmdi-innovation/">Kindeva® commemorates 70 years of pMDI Innovation</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase</title>
		<link>https://www.worldpharmatoday.com/press-releases/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 23 Mar 2026 13:33:19 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Acquisition]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/</guid>

					<description><![CDATA[<p>CVC reaffirms confidence in Syntegon&#8217;s strategic direction and continued growth potential Apollo acquires 37% minority stake and adds valuable expertise – particularly to further advance US expansion Continuation of Syntegon&#8217;s successful development: Since CVC&#8217;s investment, revenue has increased to a record EUR 1.75 billion operating profit has quadrupled Agreement provides the platform for accelerated growth [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/">CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Syntegon and Lyocontract: Growing Together</title>
		<link>https://www.worldpharmatoday.com/press-releases/syntegon-and-lyocontract-growing-together/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 13 Mar 2026 11:12:12 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/syntegon-and-lyocontract-growing-together/</guid>

					<description><![CDATA[<p>Groundbreaking ceremony for 50-million-euro investment at LYOCONTRACT in Ilsenburg, Germany Complete vial line from Syntegon for freeze-dried pharmaceuticals Close partnership and seamless processes as the key to mutual success Demand for freeze-dried parenteral products in vials is increasing steadily. This also applies to contract manufacturer LYOCONTRACT, which has been producing in Ilsenburg, Germany, since 2012. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/syntegon-and-lyocontract-growing-together/">Syntegon and Lyocontract: Growing Together</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Kindeva Appoints Mike Cowhig as Chief Legal Officer</title>
		<link>https://www.worldpharmatoday.com/press-releases/kindeva-appoints-mike-cowhig-as-chief-legal-officer/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 11 Mar 2026 07:55:56 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/kindeva-appoints-mike-cowhig-as-chief-legal-officer/</guid>

					<description><![CDATA[<p>Kindeva, a global drug delivery contract development and manufacturing organization (CDMO), has today announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization. Bringing over 25 years of experience in the life sciences industry, Mike has previously held several Senior [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/kindeva-appoints-mike-cowhig-as-chief-legal-officer/">Kindeva Appoints Mike Cowhig as Chief Legal Officer</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Inizio Ignite Builds its Connected Solution with Key Leadership Appointments</title>
		<link>https://www.worldpharmatoday.com/press-releases/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 10 Mar 2026 11:31:07 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/</guid>

					<description><![CDATA[<p>Inizio Ignite, a fully integrated advisory partner, has today announced several key leadership appointments that support the activation and scale of its evolved, unified advisory solution. Designed to help health and life science companies shape strategy, drive transformation, and deliver measurable impact, Ignite’s leadership team will be central to delivering world-class support at every stage [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/">Inizio Ignite Builds its Connected Solution with Key Leadership Appointments</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST</title>
		<link>https://www.worldpharmatoday.com/press-releases/qiagens-quantiferon-tb-gold-plus-shows-cost-effectiveness-compared-with-tst/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 10 Feb 2026 13:36:29 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/qiagens-quantiferon-tb-gold-plus-shows-cost-effectiveness-compared-with-tst-in-a-newly-published-study-in-people-with-hiv/</guid>

					<description><![CDATA[<p>QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST in a newly published study in people with HIV Peer-reviewed health-economic analysis evaluates tuberculosis infection (TBI) screening strategies among people living with HIV in Thailand QuantiFERON-TB Gold Plus reduced the modeled lifetime risk of progression to active TB among individuals with TBI by approximately 41% compared [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/qiagens-quantiferon-tb-gold-plus-shows-cost-effectiveness-compared-with-tst/">QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Inizio Evoke Appoints Kristin Ryan as EVP to Lead AI Healthcare Innovation</title>
		<link>https://www.worldpharmatoday.com/press-releases/inizio-evoke-appoints-kristin-ryan-as-evp-to-lead-ai-healthcare-innovation/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 31 Jan 2026 06:26:36 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/inizio-evoke-appoints-kristin-ryan-as-evp-to-lead-ai-healthcare-innovation/</guid>

					<description><![CDATA[<p>Kristin Ryan Joins Inizio Evoke as EVP, AI Transformation &#38; Acceleration to Advance Responsible AI in Healthcare Communications Inizio Evoke, a leading global health marketing, communications, and transformation platform, has announced the appointment of Kristin Ryan as EVP, AI Transformation &#38; Acceleration – a newly created role reflecting the company’s continued investment in responsible, scalable [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/inizio-evoke-appoints-kristin-ryan-as-evp-to-lead-ai-healthcare-innovation/">Inizio Evoke Appoints Kristin Ryan as EVP to Lead AI Healthcare Innovation</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Parenteral Drug Association to host innovation in sustainable packaging workshop at Pharmapack 2026</title>
		<link>https://www.worldpharmatoday.com/press-releases/parenteral-drug-association-to-host-innovation-in-sustainable-packaging-workshop-at-pharmapack-2026/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 12:27:58 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/parenteral-drug-association-to-host-innovation-in-sustainable-packaging-workshop-at-pharmapack-2026/</guid>

					<description><![CDATA[<p>The Parenteral Drug Association (PDA) will host a half-day workshop titled “PDA Innovation in Sustainable Packaging Workshop 2026” on Day 1 of Pharmapack Europe in Paris. Taking place on the morning of 22nd Jan, the session will explore regulatory compliance and environmental sustainability &#8211; two of the most urgent challenges in pharmaceutical packaging through expert [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/parenteral-drug-association-to-host-innovation-in-sustainable-packaging-workshop-at-pharmapack-2026/">Parenteral Drug Association to host innovation in sustainable packaging workshop at Pharmapack 2026</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Kindeva Announces Leadership Transition to Drive Strategic Growth</title>
		<link>https://www.worldpharmatoday.com/press-releases/kindeva-announces-leadership-transition-to-drive-strategic-growth/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 16 Jan 2026 09:19:34 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/kindeva-announces-leadership-transition-to-drive-strategic-growth/</guid>

					<description><![CDATA[<p>Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery. Effective January 1, 2026, David Stevens, most recently President at Kindeva, has assumed the role of [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/kindeva-announces-leadership-transition-to-drive-strategic-growth/">Kindeva Announces Leadership Transition to Drive Strategic Growth</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
